Context-dependent effectiveness of autologous platelet concentrates in regenerative endodontic procedures and periapical surgery: A systematic review and meta-analysis Authors: Shivkumar P. Mantri, Niharika A. Gupta, Sneha S. Mantri Published: 2026 ABSTRACT Objectives:To evaluate the clinical effectiveness of autologous platelet concentrates (APCs) compared with conventional approaches across regenerative endodontic contexts, including regenerative endodontic procedures (REPs) in immature and mature permanent teeth and periapical surgery.Methods:A systematic search of PubMed, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and supplementary sources was conducted from January 2000 to April 2026. Randomized and prospective clinical studies comparing APCs (platelet-rich plasma, platelet-rich fibrin, and derivatives) with conventional scaffolds or treatments were included. Outcomes assessed were clinical success, periapical healing, root development, pulp sensibility, and postoperative pain. Risk of bias was evaluated using Cochrane RoB 2 and ROBINS-I tools. Meta-analyses were performed using random-effects models with risk ratios (RRs), risk differences (RDs), or mean differences (MDs).Results:Thirty-nine studies were included. In immature teeth, APCs showed no significant difference compared with blood clot scaffolds in periapical healing (RD = 0.04; 95% confidence interval (CI): −0.08–0.16) and demonstrated comparable root development outcomes. In mature teeth, APC-based REPs showed no significant improvement in radiographic healing (RR = 0.99; 95% CI: 0.70–1.40), while pulp sensibility outcomes were highly heterogeneous and not statistically significant. In periapical surgery, APCs used as adjunctive biomaterials significantly improved radiographic healing (RR = 1.95; 95% CI: 1.27–2.98) and showed a nonsignificant reduction in postoperative pain (MD = −3.96; 95% CI: −9.36–1.44).Conclusions:APCs provide clinical outcomes comparable to conventional approaches in regenerative endodontics, particularly in immature teeth. Their benefits appear context-dependent, with improved early healing in periapical surgery but no consistent advantage in pulp sensibility or long-term outcomes. APCs should be considered biologically active adjuncts rather than replacements for conventional treatment. INTRODUCTION Regenerative endodontic procedures (REPs) have emerged as biologically based treatment strategies aimed at promoting continued root development, apical closure, and periapical healing in necrotic immature permanent teeth. As the introduction of revascularization protocols by Banchs and Trope, regenerative endodontics has evolved into a conservative alternative to traditional apexification techniques, facilitating stem cell recruitment, angiogenesis, and tissue repair within the root canal system.[123] Contemporary regenerative concepts emphasize the importance of effective canal disinfection, stem cell survival, scaffold formation, and signaling molecules for successful tissue regeneration.[4] In recent years, regenerative approaches have also been explored in mature permanent teeth with pulp necrosis and persistent periapical pathology as biologically based approaches for promoting tissue repair and periapical healing.[5] The scaffold represents a critical determinant of regenerative outcomes because it provides structural support for cellular migration, proliferation, differentiation, and vascular ingrowth. Conventionally, induced intracanal blood clot scaffolds have been widely utilized in regenerative protocols. However, autologous platelet concentrates (APCs), including platelet-rich plasma (PRP), platelet-rich fibrin (PRF), advanced PRF (A-PRF), injectable PRF (i-PRF), and concentrated growth factor (CGF), have gained increasing interest because they contain high concentrations of biologically active growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), and vascular endothelial growth factor.[678] These bioactive mediators may enhance angiogenesis, modulate inflammation, stimulate stem cell differentiation, and promote the formation of mineralized tissue and wound healing.[79] Several clinical studies have evaluated APCs as alternatives or adjuncts to conventional blood clot scaffolds in regenerative endodontics. APCs may provide advantages such as improved scaffold stability, sustained release of growth factors, enhanced handling properties, and reduced dependence on intracanal bleeding induction.[101112131415] Some studies have demonstrated favorable effects on root maturation, apical closure, dentinal wall thickening, and early periapical healing; however, findings remain inconsistent because of heterogeneity in APC preparation protocols, imaging modalities, patient age, outcome measures, and follow-up duration.[1112131415161718] In addition to REPs, APCs have also been investigated as biologically active adjuncts during endodontic microsurgery and periapical surgery. Their application in surgical defects has been associated with enhanced angiogenesis, accelerated bone healing, improved soft-tissue repair, and reduced early postoperative pain and swelling.[1920212223] Nevertheless, whether these biological advantages translate into superior long-term clinical outcomes compared with conventional surgical approaches remains uncertain. Previous systematic reviews have primarily evaluated APCs within isolated clinical contexts, such as regenerative procedures in immature teeth or surgical endodontics alone, thereby limiting a comprehensive understanding of their overall clinical effectiveness. Furthermore, emerging evidence related to APC use in mature permanent teeth and contemporary platelet derivatives has not been comprehensively synthesized. Therefore, the present systematic review and meta-analysis aimed to evaluate the effectiveness of APCs in REPs and periapical surgery involving immature and mature permanent teeth by assessing clinical and radiographic outcomes, including periapical healing, root development, pulp sensibility, postoperative pain, and clinical success. METHODS Protocol and registration This systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. The protocol was developed before the review to ensure transparency and minimize bias. It was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD420261348373). Focused question (PICO framework) The review addressed the following focused question: “In permanent teeth with pulp necrosis, what is the effectiveness of APCs compared with conventional scaffolds or treatments in REPs and periapical surgery?” The PICO framework was defined as follows: Population (P): Patients with necrotic immature teeth or mature permanent teeth with necrotic pulp and/or periapical lesionsIntervention (I): APCs, including PRP, PRF, A-PRF, i-PRF, and CGFComparator (C): Blood clot scaffold, conventional root canal treatment, no scaffold, or alternative biomaterialsOutcomes (O): Clinical success, periapical healing, root development, pulp sensibility, postoperative pain, and quality of life. Population (P): Patients with necrotic immature teeth or mature permanent teeth with necrotic pulp and/or periapical lesions Population (P): Patients with necrotic immature teeth or mature permanent teeth with necrotic pulp and/or periapical lesions Intervention (I): APCs, including PRP, PRF, A-PRF, i-PRF, and CGF Intervention (I): APCs, including PRP, PRF, A-PRF, i-PRF, and CGF Comparator (C): Blood clot scaffold, conventional root canal treatment, no scaffold, or alternative biomaterials Comparator (C): Blood clot scaffold, conventional root canal treatment, no scaffold, or alternative biomaterials Outcomes (O): Clinical success, periapical healing, root development, pulp sensibility, postoperative pain, and quality of life. Outcomes (O): Clinical success, periapical healing, root development, pulp sensibility, postoperative pain, and quality of life. Eligibility criteria Inclusion criteria Randomized controlled trials (RCTs), controlled clinical trials, or prospective clinical studiesHuman studies involving necrotic immature or mature permanent teethStudies evaluating APCs in REPs or periapical surgeryPresence of a comparator groupReporting of clinical and/or radiographic outcomesPublished in English. Randomized controlled trials (RCTs), controlled clinical trials, or prospective clinical studies Randomized controlled trials (RCTs), controlled clinical trials, or prospective clinical studies Human studies involving necrotic immature or mature permanent teeth Human studies involving necrotic immature or mature permanent teeth Studies evaluating APCs in REPs or periapical surgery Studies evaluating APCs in REPs or periapical surgery Presence of a comparator group Presence of a comparator group Reporting of clinical and/or radiographic outcomes Reporting of clinical and/or radiographic outcomes Published in English. Published in English. Exclusion criteria Case reports, case series without comparators, reviews, or nonclinical studiesAnimal or in vitro studiesStudies not involving APCsStudies focused on vital pulp therapyStudies involving apexification or nonregenerative proceduresStudies lacking extractable outcome dataDuplicate or overlapping datasets. Case reports, case series without comparators, reviews, or nonclinical studies Case reports, case series without comparators, reviews, or nonclinical studies Animal or in vitro studies Animal or in vitro studies Studies not involving APCs Studies not involving APCs Studies focused on vital pulp therapy Studies focused on vital pulp therapy Studies involving apexification or nonregenerative procedures Studies involving apexification or nonregenerative procedures Studies lacking extractable outcome data Studies lacking extractable outcome data Duplicate or overlapping datasets. Duplicate or overlapping datasets. Information sources and search strategy A comprehensive electronic search was performed in PubMed (MEDLINE) and the Cochrane Central Register of Controlled Trials. Additional sources included ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, grey literature, and reference lists of included studies. The search covered the period from January 2000 to April 2026. The last search was in April 2026. The search period was selected to capture contemporary regenerative endodontic literature following the introduction and clinical application of platelet concentrates and modern regenerative endodontic concepts in the early 2000s. Only human studies and English-language publications were included. The search strategy combined Medical Subject Headings and free-text terms related to platelet concentrates, regenerative endodontics, or periapical surgery. The complete search strategy is provided in the Supplementary Material. Study selection All records were imported into a reference management software (Zotero), and duplicates were removed. Two reviewers independently screened titles and abstracts, followed by full-text assessment based on predefined eligibility criteria. Disagreements were resolved through discussion or consultation with a third reviewer. Data extraction Study selection and data extraction were performed independently by two reviewers. They used a standardized, pilot-tested form. Extracted data included study characteristics, population details, intervention and comparator characteristics, outcomes, follow-up duration, and relevant statistical measures. Discrepancies were resolved by consensus. Risk of bias assessment Two reviewers independently assessed the risk of bias. RCTs were evaluated using the Cochrane Risk of Bias Tool 2, and nonrandomized studies were assessed using the ROBINS-I tool. Studies were categorized as low risk, some concerns, or high risk of bias. Disagreements were resolved through discussion. Data synthesis and statistical analysis A qualitative synthesis was initially performed due to heterogeneity in study design, interventions, and outcomes. Studies were categorized into: REPs in immature teethREPs in mature teethPeriapical surgery. REPs in immature teeth REPs in immature teeth REPs in mature teeth REPs in mature teeth Periapical surgery. Periapical surgery. A meta-analysis was conducted when at least two studies reported comparable outcomes. Random-effects models were applied. Effect measures included: Risk ratios (RRs) for dichotomous outcomesRisk difference (RD) for zero-event dataMean difference (MD) for continuous outcomes. Risk ratios (RRs) for dichotomous outcomes Risk ratios (RRs) for dichotomous outcomes Risk difference (RD) for zero-event data Risk difference (RD) for zero-event data Mean difference (MD) for continuous outcomes. Mean difference (MD) for continuous outcomes. Statistical heterogeneity was assessed using the I2 statistic. Where pooling was not feasible, findings were summarized narratively. Publication bias was planned to be assessed using funnel plots when ≥10 studies were available. Outcome measures Primary outcomes Clinical successPeriapical healing. Clinical success Clinical success Periapical healing. Periapical healing. Secondary outcomes Root developmentPulp sensibilityPostoperative painQuality of life. Root development Root development Pulp sensibility Pulp sensibility Postoperative pain Postoperative pain Quality of life. Quality of life. RESULTS Study selection A total of 756 records were identified through database searches and additional sources. After removing 150 duplicates, 606 records were screened based on titles and abstracts, of which 533 were excluded. Seventy-three full-text articles were assessed for eligibility, and 34 studies were excluded due to inappropriate study design, absence of APC intervention, nonrelevant clinical context, insufficient data, or duplication. Ultimately, 39 studies were included in the qualitative synthesis. The study selection process is presented in Figure 1, and the detailed search strategy is provided in Supplementary Table 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 flow diagram illustrating the study selection process, including identification, screening, eligibility assessment, and final inclusion of 39 studies Supplementary Table 1Search strings and retrieved data tableDatabaseSearch StringSearch dateCoverageFiltersRecords retrieved (n)PubMed (MEDLINE)( (“Platelet-Rich Plasma”[Mesh] OR “Platelet-Rich Fibrin”[Mesh]) OR (“platelet-rich plasma”[tiab] OR PRP[tiab] OR “platelet-rich fibrin”[tiab] OR PRF[tiab] OR “advanced platelet-rich fibrin”[tiab] OR A-PRF[tiab] OR “injectable platelet-rich fibrin”[tiab] OR i-PRF[tiab] OR “concentrated growth factor”[tiab] OR CGF[tiab] OR “platelet concentrate*”[tiab]) ) AND ( (“regenerative endodontics”[tiab] OR revascularization[tiab] OR “pulp revascularization”[tiab] OR “immature teeth”[tiab] OR “immature permanent teeth”[tiab] OR apexogenesis[tiab] OR “necrotic pulp”[tiab]) OR (“periapical surgery”[tiab] OR “endodontic surgery”[tiab] OR apicoectomy[tiab] OR “apical surgery”[tiab] OR “periapical lesion”[tiab] OR “apical periodontitis”[tiab]) )April 04, 20262000–2026Human, English182Cochrane CENTRAL(platelet rich plasma OR platelet-rich plasma OR PRP OR platelet rich fibrin OR platelet-rich fibrin OR PRF OR advanced platelet rich fibrin OR A-PRF OR injectable platelet rich fibrin OR i-PRF OR concentrated growth factor OR CGF OR autologous platelet concentrate OR platelet) AND (regenerative endodontic* OR pulp revascularization OR revascularization OR pulp regeneration OR apexogenesis OR maturogenesis OR periapical surgery OR apicoectomy OR endodontic surgery OR periradicular surgery OR endodontic)April 04, 2026Inception–2026None488ClinicalTrials.govplatelet rich fibrin endodontics platelet rich plasma periapical surgeryApril 05, 2026Inception–2026None42WHO ICTRPplatelet rich fibrin endodontics platelet rich plasma periapical surgeryApril 05, 2026Inception–2026None18Google Scholar and Manual search Grey literature“platelet rich fibrin” regenerative endodontics randomized controlled trialApril 07, 2026Not restrictedNone26 Search strings and retrieved data table Characteristics of included studies The included studies comprised predominantly RCTs, along with a limited number of nonrandomized prospective clinical studies. Sample sizes ranged from 16 to 88 teeth. Participants included pediatric, adolescent, and adult populations. Studies were categorized into three clinical domains: REPs in immature teeth,[101112131415161718242526272829303132] REPs in mature teeth,[533343536373839] and periapical surgery.[19202122234041424344454647] In immature teeth, most studies evaluated PRP, PRF, and related derivatives (i-PRF, A-PRF, CGF) compared with blood clot scaffolds. Follow-up periods ranged from 12 to 36 months, with outcomes including root development, apical closure, periapical healing, and clinical success. In mature teeth, APC-based regenerative approaches were compared with conventional endodontic treatment or other scaffolds. Outcomes were assessed with radiographs, pulp sensibility tests, and clinical evaluations. Periapical surgery studies evaluated APCs as adjuncts to conventional surgical procedures, assessing radiographic healing, lesion volume reduction, postoperative pain, and quality of life [Table 1]. Table 1Characteristics of the included studiesREP immature teeth Study and yearStudy typeSample size (teeth/patients)Age range (years)Primary intervention scaffoldPrimary comparator scaffoldFollow-up Period (months)Key outcome measuresElSheshtawy et al. (2020)[10]RCT (single-blinded)31/267–18 (mean 12.66±4.47)PRPBlood clot12Root length, apical foramen width, dentin thickness, root area, periapical area (2D/CBCT)Rizk et al. (2020)[24]RCT (double-blinded)26/258–14 (mean 9±1)PRPPRF12Root length, apical diameter, dentin width, bone density (radiographs)Meschi et al. (2021)[14]Multicenter controlled trial (nonrandomized)23/296–25LPRFBlood clot (REP without LPRF)36Root development (length, volume, thickness), apical area, periapical bone healing (PR/CBCT)Ulusoy et al. (2019)[11]RCT (prospective)88/678–11PRP, PRF, platelet pelletBlood clotMean 28.25±1.2Root length/width, RRA, RCA, apical closure, periapical healing (radiographs)Ragab et al. (2019)[25]RCT22/227–12PRF+blood clotBlood clot12Root length, apical/cervical bridges, periapical radiolucency (radiographs)Rizk et al. (2019)[26]RCT (split-mouth, double-blinded)26/138–14 (mean 9.08±1.038)PRPBlood clot12Root length, apical diameter, dentin thickness, bone density (radiographs)Rizk et al. (2020)[27]RCT (split-mouth, double-blinded)26/138–14 (mean 9.08±1.04)PRPBlood clot12Root length, apical diameter, dentin thickness, bone density (radiographs)Qamar et al. (2025)[28]RCT28/248–12A-PRFBlood clot12Root length, apical width, root thickness (radiographs)Jadhav et al. (2012)[13]Pilot RCT20/2015–28 (mean 19.9)PRP+collagen spongeBlood clot12Root length, apical closure, dentin thickness, periapical healing (radiographs)Bezgin et al. (2015)[12]RCT20/20 (15 analyzed)7–12PRPBlood clot18RRA, apical closure, periapical healing (radiographs)Mittal et al. (2024)[29]RCT (double-blinded, superiority)52/5610–35Double antibiotic chitosan hydrogelPRF, double antibiotic hydrogel, chitosan hydrogel12Root length, apical closure, dentin thickness, periapical healing (CBCT)Mohamed et al. (2024)[18]RCT24/239–24i-PRFPRP12Root length, canal diameters (3D scans/CBCT)Asal et al. (2024)[30]RCT (single-blinded)24/247–11PRFTreated dentin matrix15Root length, apical diameter, RRA, lesion size (CBCT)Kavitha et al. (2022)[31]RCT16/10Mean 22–25PRFCGF18Root length, apical foramen, lesion volume (CBCT)Zhang and Sheng (2024)[16]RCT (single-blinded)54/56Mean 10.67±1.21–1.44CGFBlood clot12Root length, apical width, RRA, periapical healing (radiographs)Markandey and Das Adhikari (2022)[17]RCT35/23Not reportedPRP, PRFBlood clot12–24Root length, apical diameter, root wall thickness, lesion healing (IOPAR/CBCT)Shivashankar et al. (2017)[15]RCT (triple-blind)60/606–28PRP, PRFInduced bleeding (blood clot)12Root length, apical response, dentin thickness, periapical index (radiographs) REP immature teeth Study and year Study type Sample size (teeth/patients) Age range (years) Primary intervention scaffold Primary comparator scaffold Follow-up Period (months) Key outcome measures Gupta et al. (2022)[32]RCT36/Not reportedNot reportedDexamethasone-coated bioglass nanofiberPRF, bioglass nanofiber12Root length, apical closure, dentin thickness, periapical index (radiographs)Ahmed et al. (2023)[33]RCT28 patientsAdults 18–45 years; necrotic mature mandibular molars with chronic periapical periodontitisPRP revascularizationConventional endodontic treatment12 monthsPain (NRS), radiographic healing, pulp sensibility, clinical successAlshahhoud et al. (2024)[34]RCT30 teeth (24 patients)15–45 years; necrotic mature single-rooted teeth with periapical lesionsChitosan scaffolds+blood clotBlood clot alone; native/enzymatically modified chitosan+blood clot12 monthsRadiographic healing, pulp sensibility, clinical successSalah et al. (2025)[35]RCT18 patientsAdults; necrotic mature maxillary incisors with periapical lesionsCGF revascularizationPRF revascularization12 monthsRadiographic healing, pulp sensibilityAli et al. (2021)[36]RCT28 patients~18–30 years; necrotic mature second premolars with periapical lesionsPRP or PRF regenerationPRP vs. PRF12 monthsRadiographic healing (CBCT), pulp sensibility, survivalDarwish et al. (2025)[37]RCT51 patientsAdults 18–35 years; necrotic mature anterior teeth with chronic periapical periodontitisS-PRF or A-PRFBlood clot18 monthsRadiographic healing (PAI), pulp sensibility, clinical successWahba et al. (2025)[38]RCT54 teeth (48 adolescents)Adolescents 13–16 years; retreated mature maxillary incisors with periapical radiolucenciesPRF in REP retreatmentBlood clot in REP retreatment12 monthsRadiographic healing (CBCT), pulp sensibility, clinical successMittal et al. (2021)[39]RCT36 teeth16–34 years; necrotic mature teeth with periapical radiolucency≤1.5 cmPRF scaffoldBlood clot; collagen; hydroxyapatite-collagen12 monthsPulp sensibility, radiographic healing, clinical successElheeny et al. (2024)[5]RCT66 teethAdolescents 11–17 years; retreated mature incisors with periapical periodontitisREP with blood clotNonsurgical root canal retreatment12 monthsRadiographic healing (PAI), pulp sensibility, clinical success Periapical surgery Study and year Study type Sample size Population Platelet concentrate used Comparator Primary outcome measure Follow-up period Dhamija et al. (2020)[19]RCT34 patientsAdults with through-and-through periapical lesionsPRP (graft in bone defect)Conventional surgery without PRP3D CBCT volume reduction, success rates12 monthsKarkle et al. (2025)[23]RCT43 patientsAdults with periradicular lesionsA-PRF (regenerative material)Conventional microsurgery without A-PRFCBCT lesion volume, Molven’s/Penn criteria6 and 12 monthsEl-Kabbaney and Yousef (2021)[40]Prospective clinical trial28 teeth in 25 patientsAdults with periapical bony defectsPRF (graft in bony crypt)Conventional microsurgery without graft2D radiographic healing (Molven’s criteria)12 monthsGarg et al. (2023)[41]Prospective RCT19 patientsAdults (18–40 years) with failed RCTPRF (gel and membrane)FDBA (with PRF membrane)2D radiographic healing (Molven’s criteria)1, 3, 6, 12 monthsGulsever et al. (2025)[42]RCT64 adultsAdults with large periapical lesions (>10 mm)L-PRF (in bone defect)Apicoectomy or curettage without L-PRF2D PALA reduction, PAI scores1 week to 12 monthsSoto-Peñaloza et al. (2020)[20]RCT50 patientsAdults with upper maxillary lesions (6–12 mm)A-PRF+ (membrane)Conventional surgery without A-PRF+VAS pain, quality of life (Likert scales)1 weekAngerame et al. (2015)[43]Randomized pilot trial11 patientsAdults with chronic apical periodontitisPRF (adjunct)Conventional surgery without PRF2D radiographic healing (Molven’s), pain/swellingUp to 12 monthsLin et al. (2025)[22]Prospective clinical trial68 teeth in 56 patientsAdults (mean age 27–31 years) with periapical lesionsCGF (scaffold)Microsurgery without CGFCBCT bone volume ratio, pain/swellingAverage 18 monthsKaran and Aricioğlu (2020)[44]Prospective RCT40 lesions in 33 patientsAdults (18–50 years) with single-rooted teeth lesionsPRF (alone or with MTA)MTA alone or control (resection only)3D CBCT volume/density12 monthsYou et al. (2023)[45]RCT18 patientsAdults (17–68 years) with small maxillary anterior lesions (<10 mm)PRF or CGF (membranes)Microsurgery without concentratesCBCT bone defect volume1 week, 3, 6 monthsDel Fabbro et al. (2012)[21]Randomized single-blind trial36 patientsAdults (31–62 years) with maxillary chronic apical periodontitis (8–12 mm)PRGF (liquid/clot)Conventional surgery without PRGFVAS pain, swelling, quality of life1 weekTiwari et al. (2020)[46]Prospective clinical trial20 patientsMales (25–35 years) with anterior periapical pathology (>5 mm)PRF (alone or with hydroxyapatite/alendronate)No material (blood clot)CBCT volume change12 monthsMajor et al. (2025)[47]Single-blind RCT pilot20 patientsAdults with persistent periapical lesionsPRF (membranes)Conventional apicoectomy without PRF3D swelling volume, VAS pain, PROMIS-29+27 daysRCT: Randomized controlled trials, PRP: Platelet-rich plasma, CBCT: Cone-beam computed tomography, 2D: Two-dimensional, PRF: Platelet-rich fibrin, L-PRF: Leukocyte-PRF, REPs: Regenerative endodontic procedures, PR: Periapical radiography, RRa: Radiographic root area, RCA: Radiographic canal area, 3D: Three-dimensional, CGF: Concentrated growth factor, NRS: Numerical Rating Scale, IOPAR: Intraoral periapical radiography, S-PRF: Sticky PRF, A-PRF: Advanced PRF, PAI: Periapical index, MTA: Mineral trioxide aggregate, PRGF: Plasma rich in growth factors, VAS: Visual Analog Scale Characteristics of the included studies RCT: Randomized controlled trials, PRP: Platelet-rich plasma, CBCT: Cone-beam computed tomography, 2D: Two-dimensional, PRF: Platelet-rich fibrin, L-PRF: Leukocyte-PRF, REPs: Regenerative endodontic procedures, PR: Periapical radiography, RRa: Radiographic root area, RCA: Radiographic canal area, 3D: Three-dimensional, CGF: Concentrated growth factor, NRS: Numerical Rating Scale, IOPAR: Intraoral periapical radiography, S-PRF: Sticky PRF, A-PRF: Advanced PRF, PAI: Periapical index, MTA: Mineral trioxide aggregate, PRGF: Plasma rich in growth factors, VAS: Visual Analog Scale Risk of bias assessment Among the 36 RCTs, 21 studies were assessed as low risk of bias, 12 studies demonstrated some concerns, and 3 studies were classified as high risk of bias. The three nonrandomized studies assessed using ROBINS-I demonstrated moderate to serious risk of bias, primarily due to confounding and selection bias [Figure 2 and Supplementary Tables 2 and 3]. The distribution of risk-of-bias judgments across domains is presented in Supplementary Figure 1. Risk-of-bias assessment of the included studies. (a) Immature teeth (RoB 2); (b) Mature teeth (RoB 2); (c) Periapical surgery (RoB 2); (d) Immature teeth (ROBINS-I); and (e) Periapical surgery (ROBINS-I). Traffic-light plots indicate low (green), some concerns/moderate (yellow), and high/serious (red) risk of bias. Supplementary Table 2Risk of bias of randomized studiesREP Immature teeth (Primary outcome assessed: Periapical healing [radiographic/CBCT]) StudyRandomizationDeviationsMissing DataOutcome MeasurementSelective ReportingOverall RiskElSheshtawy, 2020[1]Some concernsLowLowSome concernsLowSome concernsRizk, 2020[2]LowLowLowLowLowLowUlusoy, 2019[4]LowLowLowSome concernsLowSome concernsRagab, 2019[5]Some concernsLowLowSome concernsLowSome concernsRizk, 2019[6]LowLowLowLowLowLowRizk, 2020 split-mouth[7]LowLowLowLowLowLowQamar, 2025[8]Some concernsLowLowSome concernsLowSome concernsJadhav, 2012[9]HighLowLowSome concernsSome concernsHighBezgin, 2015[10]Some concernsLowSome concernsSome concernsLowSome concernsMittal, 2024[11]LowLowLowLowLowLowAbo-Heikal, 2024[12]LowLowLowLowLowLowAsal, 2024[13]Some concernsLowLowLowLowSome concernsKavitha, 2022[14]Some concernsLowSome concernsSome concernsLowSome concernsZhang, 2024[15]LowLowLowSome concernsLowSome concernsMarkandey, 2022[16]Some concernsLowLowSome concernsLowSome concernsShivashankar, 2017[17]LowLowLowLowLowLow REP Mature Teeth Study Randomization process Deviations from intended interventions Missing outcome data Measurement of outcome Selection of reported result Overall Bias Elsayed et al. (2023)LowSome concernsLowLowLowSome concernsAlshahhoud et al. (2024)LowSome concernsLowLowLowSome concernsSalah et al. (2025)LowSome concernsLowLowLowSome concernsAli et al. (2021)LowSome concernsLowLowLowSome concernsDarwish et al. (2025)LowSome concernsLowLowLowSome concernsOmar et al. (2025)LowSome concernsLowLowLowSome concernsMittal et al. (2021)LowSome concernsLowSome concernsLowSome concernsElheeny et al. (2024)LowSome concernsLowLowLowSome concerns Periapical surgery Study Randomization process Deviations from intended interventions Missing outcome data Measurement of outcome Selection of reported result Overall Bias Dhamija, 2020LowSomeLowLowSomeSomeKarkle, 2025LowLowLowLowLowLowGulsever, 2025LowLowLowLowLowLowSoto-Peñaloza, 2020LowLowLowLowLowLowYou, 2023SomeSomeLowLowSomeSomeDel Fabbro, 2012LowLowLowLowLowLowMajor et al. (2025)[47]LowSomeLowLowSomeSomeREP: Regenerative endodontic procedures, CBCT: Cone beam computed tomography Risk of bias of randomized studies REP: Regenerative endodontic procedures, CBCT: Cone beam computed tomography Supplementary Table 3Risk of bias of nonrandomized studiesStudyConfoundingSelectionClassificationDeviationsMissingMeasurementReportingOverall REP immature teeth Meschi et al. (2021)SeriousModerateLowLowModerateLowLowSerious Periapical Surgery El-Kabbaney, 2021ModerateModerateLowModerateLowLowModerateModerateLin, 2025ModerateModerateLowModerateLowLowModerateModerateTiwari, 2020ModerateModerateLowModerateLowLowModerateModerateAngerame, 2015SeriousModerateLowModerateLowSeriousModerateSeriousREP: Regenerative endodontic procedures Risk of bias of nonrandomized studies REP: Regenerative endodontic procedures Qualitative synthesis Regenerative endodontic procedures in immature teeth Root length changes Across RCTs, APCs (PRP, PRF, CGF) demonstrated root length increases comparable to blood clot scaffolds, with predominantly nonsignificant differences (P > 0.05).[141626] Isolated studies reported greater gains with PRP (P = 0.001), while multicenter cone beam computed tomography (CBCT)-based analyses showed no significant difference (P = 0.72).[1426] i-PRF and PRP demonstrated comparable outcomes (P = 0.542).[18] Apical closure Apical closure and diameter reduction were comparable between APCs and blood clot scaffolds, with closure rates ranging from 60% to 82.4% and largely nonsignificant differences.[111618] i-PRF demonstrated superiority over PRP in one study (P = 0.008), but not compared to blood clot scaffolds.[18] Combined scaffold approaches (PRF + blood clot) showed improved barrier formation in selected cases.[25] Dentin thickness and root area Increases in dentin thickness and root area were generally comparable between APCs and blood clot scaffolds, with no consistent significant differences.[1216] PRP demonstrated marginal advantages in some studies, whereas blood clot scaffolds showed higher rates of canal obliteration.[1124] Periapical healing High rates of periapical healing were observed in both groups (approximately 87%–100%), with no significant intergroup differences.[101416] Some studies reported faster early healing with PRP, although overall success rates remained comparable.[1516] Clinical outcomes Clinical success rates were consistently high (92.6%–100%), with symptom resolution and a low incidence of adverse events. APCs were associated with reduced discoloration and calcification in some studies,[1726] while vitality responses remained limited across both groups.[1618] Regenerative endodontic procedures in mature teeth Radiographic healing Both APC-based regenerative approaches and conventional endodontic treatment resulted in significant reductions in lesion size, with no consistent differences between groups.[53338] Short-term variations were observed in specific subgroups; however, long-term outcomes were comparable. Pulp sensibility APCs showed higher pulp sensibility responses in some studies; however, findings were inconsistent. PRF showed higher responses in thermal and electric pulp testing in several studies,[3839] with increasing rates of positive responses over time.[36] Postoperative pain and clinical success Postoperative pain levels were low and generally comparable across groups, although PRP showed a short-term advantage in early pain reduction.[33] Clinical success rates were high (82.4%–100%), with minimal complications and favorable long-term outcomes.[536373839] Periapical surgery Radiographic healing APCs demonstrated improved early radiographic healing and lesion volume reduction compared with control groups.[194045] However, differences between groups decreased over longer follow-up periods. Variability in outcomes was observed depending on lesion size and imaging modality. Comparisons with other materials APCs showed faster early healing compared with graft materials (e.g., PRF vs. FDBA), although long-term outcomes were generally comparable.[4146] No consistent additional benefit was observed when combined with materials such as mineral trioxide aggregate (MTA).[44] Clinical outcomes APCs were associated with reduced postoperative pain, swelling, and improved quality of life in the early postoperative period.[202122] These benefits were most pronounced during the initial healing phase. Quantitative synthesis (meta-analysis) Immature teeth The meta-analysis of periapical healing included three studies and was performed using a random-effects model with RD as the effect measure. The pooled estimate showed no statistically significant difference between APCs and blood clot scaffolds (RD = 0.04; 95% CI: −0.08–0.16; I2 = 38%) [Figure 3a]. Forest plots of outcomes comparing autologous platelet concentrates (APCs) versus control using random-effects models. (a) Radiographic success in immature permanent teeth analyzed using the Mantel–Haenszel method. Effect size is presented as risk difference with 95% confidence intervals (CIs). (b) Clinical and/or radiographic success in mature permanent teeth was analyzed using the Mantel–Haenszel method. Effect size is expressed as risk ratio (RR) with 95% CI. The pooled estimate showed no statistically significant difference between groups (RR = 0.99; 95% CI: 0.70–1.40; P = 0.94), with substantial heterogeneity (I2 = 71%). (c) Pulp sensibility outcomes in mature permanent teeth analyzed using the Mantel–Haenszel method. Effect size is expressed as RR with 95% CI. The pooled analysis showed no statistically significant difference between groups (RR = 5.31; 95% CI: 0.00–142; P = 0.79), with considerable heterogeneity (I2 = 99%). One study was not estimable due to zero events in both groups. (d) Radiographic healing following periapical surgery was analyzed using the Mantel–Haenszel method. Effect size is expressed as RR with 95% CI. The pooled estimate demonstrated a statistically significant improvement with APCs (RR = 1.95; 95% CI: 1.27–2.98; P = 0.002), with no observed heterogeneity (I2 = 0%). (e) Postoperative pain following periapical surgery was analyzed using the inverse-variance method. Effect size is expressed as mean difference (MD) in Visual Analog Scale scores with 95% CI. The pooled estimate showed no statistically significant reduction in postoperative pain with APCs (MD = −3.96; 95% CI: −9.36–1.44; P = 0.15), with moderate heterogeneity (I2 = 59%). APCs: Autologous platelet concentrates, CI: Confidence interval, VAS: Visual Analog Scale, SD: Standard deviation Two studies reported complete healing in both groups (100% event rates), resulting in a ceiling effect that limited discrimination between interventions and reduced statistical power to detect differences. Due to heterogeneity in outcome reporting, meta-analysis was not performed for root length, dentin thickness, or apical closure. Mature teeth Three studies were included in the meta-analysis for radiographic healing. The pooled estimate showed no statistically significant difference between APCs and control interventions (RR = 0.99; 95% CI: 0.70–1.40; I2 = 71%) [Figure 3b]. Meta-analysis showed no statistically significant difference in pulp sensibility between groups (RR = 5.31; 95% CI: 0.00–142; P = 0.79; I2 = 99%), with highly imprecise and heterogeneous estimates [Figure 3c]. Postoperative pain was not pooled due to heterogeneity in outcome reporting. Periapical surgery Meta-analysis of radiographic success, based on two studies, suggested a statistically significant benefit of adjunctive APC use compared with conventional treatment (RR = 1.95; 95% CI: 1.27–2.98; I2 = 0%) [Figure 3d]. Pooling of two studies for postoperative pain showed a nonsignificant reduction favoring APCs (MD = −3.96; 95% CI: −9.36–1.44; I2 = 59%) [Figure 3e]. Sensitivity analysis, including a nonrandomized study, yielded similar estimates; however, excluding this study resulted in insufficient data for pooling. Given the small number of studies and wide confidence intervals (CIs), pooled estimates should be interpreted with caution. Sensitivity analysis Sensitivity analyses were conducted to evaluate the robustness of the pooled estimates. Limited sensitivity analyses, including a leave-one-out approach, were performed, whereby each study was sequentially excluded to assess its influence on the overall effect size. The direction and magnitude of the pooled estimates remained largely unchanged after excluding individual studies, suggesting that no single study disproportionately influenced the results. In addition, analyses were repeated by excluding studies with a higher risk of bias. The overall findings remained consistent, suggesting that the results were not significantly affected by methodological quality. Due to the limited number of studies within each subgroup, further sensitivity analyses (such as alternative statistical models) were not considered meaningful. Overall, the findings appear relatively stable; however, interpretation is limited by the small number of included studies. Publication bias Publication bias was not formally assessed using funnel plots due to the small number of studies included in each analysis (<10), which limits the reliability of such methods. In addition, heterogeneity across clinical scenarios further precluded meaningful assessment. A comprehensive search strategy was employed to minimize potential bias. Summary of evidence Across all clinical domains, APCs demonstrated outcomes comparable to conventional approaches for radiographic healing and overall clinical success. In immature teeth, APCs and blood clot scaffolds showed similar effectiveness across root development and periapical healing outcomes. In mature teeth, APCs showed higher point estimates for pulp sensibility; however, no statistically significant difference was observed, while radiographic healing remained comparable. In periapical surgery, APCs were associated with improved early healing, while postoperative pain outcomes were comparable between groups, although long-term outcomes were generally comparable. The certainty of evidence ranged from very low to moderate to high depending on the outcome and clinical context, with limitations primarily related to heterogeneity, small sample sizes, variability in outcome reporting, and methodological constraints of included studies [Table 2]. Table 2Summary of findingsAPCs versus blood clot in REP immature teeth OutcomeEffect estimateParticipants (studies)CertaintyComments/notesPeriapical healingRD=0.04 (−0.08 to 0.16)~50 teeth (3 studies→1 informative)Very lowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: risk of bias, inconsistency and imprecisionApical closureNo significant difference (60%–82%)~150–200 teethLowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecisionRoot lengthNo consistent difference~200+teethLowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecisionDentin thicknessMixed results~200+teethVery lowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecisionBone densitySlight APC advantage (single study)<100 teethVery lowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecisionClinical success92.6%–100% both groups>300 teethLowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecisionVitality response0%–50%, inconsistentLimitedVery lowPeriapical healing meta-analysis is limited by the ceiling effect and zero-event studies Sensitivity analysis performed excluding double-zero studies Certainty assessed using GRADE approach Certainty downgraded for: Risk of bias, inconsistency and imprecision REP mature teeth Outcomes Anticipated absolute effects (95% CI) Relative effect (95% CI) Participants (studies) Certainty Radiographic healing85→91 per 100 (82–100)RR=0.99 (0.70–1.40)64 (3 RCTs)Moderate Radiographic healing downgraded for inconsistency (I2=71%)Pulp sensibility16→51 per 100 (28–76)RR 5.31 (0.00–142)59 (3 RCTs)Very low certaintyPostoperative painNot estimableNot pooled28 (1 RCT)Low Postoperative pain downgraded for imprecision and heterogeneity APCs in periapical surgery Outcomes Number of studies (Participants) Effect estimate Certainty of Evidence (GRADE) Comments Radiographic success2 studies (n=60)RR=1.95 (95% CI: 1.27–2.98)ModerateDowngraded for inclusion of nonrandomized study and small sample sizePostoperative pain2 studies (n=70)MD=−3.96 (95% CI: −9.36 to 1.44)ModerateDowngraded for imprecision and indirectness (different pain scales)Radiographic volume reduction3 studiesNot pooledLowInconsistent reporting and lack of usable quantitative dataRD: Risk differences, APCs: Autologous platelet concentrates, CI: Confidence interval, RCT: Randomized controlled trials, RR: Risk ratios, MD: Mean differences, REPs: Regenerative endodontic procedures, GRADE: Grading of Recommendations Assessment, Development, and Evaluation Summary of findings RD: Risk differences, APCs: Autologous platelet concentrates, CI: Confidence interval, RCT: Randomized controlled trials, RR: Risk ratios, MD: Mean differences, REPs: Regenerative endodontic procedures, GRADE: Grading of Recommendations Assessment, Development, and Evaluation DISCUSSION The present systematic review and meta-analysis evaluated the clinical effectiveness of APCs in REPs and periapical surgery. Overall, the evidence indicates that APCs appear comparable to conventional approaches for hard tissue healing and may offer additional biological advantages in specific contexts; however, evidence for improved pulp sensibility remains uncertain. Meta-analysis demonstrated no significant difference in periapical healing between APCs and control interventions in both immature and mature teeth, whereas significant improvement in radiographic healing was observed, with postoperative pain reduction not statistically significant. Although higher point estimates were observed, meta-analysis did not demonstrate a statistically significant difference in pulp sensibility, and results were highly imprecise. However, the certainty of evidence varied across outcomes due to heterogeneity in study design, outcome assessment, and reporting, suggesting a potential role for APCs as biologically active adjuncts rather than definitive replacements for conventional treatment modalities. Regenerative endodontic procedures in immature teeth Principal findings and interpretation The present synthesis indicates that APCs, including PRP and PRF, achieve root maturation outcomes that are broadly comparable to those of blood clot scaffolds in REPs. Moderate certainty evidence suggests equivalence in apical closure (60%–82.4%)[11] and periapical healing (87%–100%),[101416] while moderate certainty applies to dentin thickness and root length due to heterogeneity in imaging modalities.[1014] These findings are consistent with pooled estimates demonstrating no significant difference in periapical healing (RD = 0.04; 95% CI: −0.08–0.16; I2 = 38%), suggesting clinical equivalence between APCs and blood clot scaffolds. Mechanistically, both APCs and blood clots provide growth factors (e.g., PDGF, TGF-β) that recruit stem cells of the apical papilla and promote odontoblastic differentiation and mineralized tissue formation.[1317] APCs may confer a marginal advantage in bone density (65.08 ± 30.04 vs. 58.96 ± 19.95 grey values, P = 0.027)[26] through sustained growth factor release, thereby enhancing angiogenesis and osteogenesis. A consistent pattern indicates potential procedural advantages of APC in terms of procedural reliability, including avoidance of bleeding induction in cases achieving 73.9% closure[11] and reduced canal obliteration (54.55% vs. 91.67%),[17] potentially preserving retreatment options. Confidence in healing outcomes is strengthened by consistent RCT designs and homogeneous populations,[101114] whereas outcomes of root development remain less certain, as isolated significant findings (e.g., P = 0.005)[16] likely reflect procedural variability rather than true biological differences. Importantly, low vitality response rates (0%–50%)[1718] highlight the lack of definitive evidence for complete regeneration of the pulp–dentin complex, representing a key biological limitation. Comparison with existing literature These findings align with previous literature demonstrating that REPs provide conservative, biologically driven alternatives to apexification, achieving high healing rates (92.6%–100%)[101416] through effective disinfection and stem cell recruitment. Earlier reports suggesting PRP-enhanced outcomes (P = 0.02)[13] are biologically plausible but not consistently reproduced in larger or multicenter studies. Discrepancies in root development outcomes likely reflect heterogeneity in patient age and baseline lesion characteristics. Younger patients generally demonstrate greater regenerative potential, while more extensive pre-operative periapical lesions may adversely affect regenerative outcomes.[14] Differences in imaging modalities (two-dimensional vs. CBCT) further contribute to variability, as CBCT detects subtle volumetric changes and canal obliteration that are not visible on conventional radiographs.[1014] GRADE assessment indicates moderate certainty for periapical healing, moderate certainty for root development outcomes, and low certainty for true pulp vitality regeneration. Certainty was downgraded for root outcomes due to heterogeneity and for vitality outcomes due to indirectness and lack of histological confirmation. Practical implications Clinically, APCs are particularly valuable in cases where bleeding induction is unreliable, especially in pediatric patients (7–18 years), offering improved scaffold stability and potentially enhanced apical closure (P = 0.008).[18] From a public health perspective, APCs may reduce long-term fracture risk by improving root development (19.6% ±12.7% vs. 10.9% ± 7.7%),[16] supporting their integration into trauma management protocols. Standardization of APC preparation (e.g., low-speed centrifugation) is essential to minimize variability.[18] Despite these advantages, meta-analysis confirms equivalence in healing outcomes, indicating that APCs should be considered adjunctive rather than replacement therapies. Generalizability remains limited due to the predominance of anterior teeth and the lack of evidence in adult populations.[101416] Regenerative endodontic procedures in mature teeth Principal findings and interpretation In mature teeth, APCs demonstrate radiographic healing and clinical success comparable to conventional endodontic treatment, supported by a meta-analysis showing no significant difference (RR = 0.99; 95% CI: 0.70–1.40; I2 = 71%), reflecting moderate-certainty evidence. APCs showed higher point estimates for pulp sensibility; however, the difference was not statistically significant and was associated with substantial heterogeneity (RR = 5.31; 95% CI: 0.00–142) (I2 = 99%), representing low certainty evidence. Clinically, this is reflected in higher sensibility rates (e.g., 66.6% vs. 11.1%).[3739] Although no statistically significant difference in radiographic healing was observed, higher point estimates for pulp sensibility may suggest a potential clinical trend, though the evidence remains highly uncertain. This divergence highlights a biological trade-off: conventional treatment ensures predictable infection control, whereas APC-based REPs enable neurovascular regeneration via growth factor–mediated angiogenesis and neurogenesis.[33] Comparison with literature The equivalence in healing outcomes supports prior evidence emphasizing antimicrobial efficacy as the primary determinant of periapical repair.[535] Variability in sensibility outcomes likely reflects differences in scaffold preparation (e.g., PRF vs. A-PRF), growth factor concentration, and patient age.[537] The pooled estimates further support these findings, demonstrating comparable healing outcomes, while sensibility recovery showed higher point estimates but no statistically significant difference. GRADE assessment indicates moderate certainty for radiographic healing, very low certainty for pulp sensibility recovery, and low certainty for pain outcomes due to inconsistent reporting. Practical implications APCs, particularly PRF, should be considered in younger patients where preservation of pulp vitality is desired.[539] Conversely, conventional retreatment remains appropriate in older or complex cases with limited regenerative potential.[5] Standardization of scaffold preparation and case selection is essential to optimize outcomes.[3536] From a broader perspective, regenerative approaches may improve long-term tooth function and patient-centered outcomes. Periapical surgery Principal findings and interpretation APCs were associated with enhanced early radiographic healing, while a nonsignificant reduction in postoperative pain was observed. Meta-analysis demonstrated improved radiographic success (RR = 1.95; 95% CI: 1.27–2.98; I2 = 0%), representing moderate-certainty evidence, and a nonsignificant reduction in postoperative pain (MD = −3.96; 95% CI: −9.36–+1.44; I2 = 59%), indicating moderate-certainty evidence. These findings suggest that adjunctive APC use may be associated with enhanced healing kinetics through growth factor–mediated angiogenesis and osteogenesis, resulting in accelerated bone formation and improved early tissue regeneration.[1922] APCs may modulate inflammation, reducing swelling and improving early postoperative recovery.[2042] However, the convergence of long-term outcomes suggests that APCs primarily influence the rate rather than the extent of healing. Comparison with literature These findings align with the existing literature supporting the use of bioactive adjuncts in endodontic surgery. While materials such as MTA provide effective sealing,[44] APCs may enhance early healing dynamics through biological stimulation. Variability in outcomes, particularly with A-PRF, likely reflects differences in preparation protocols and growth factor release kinetics.[2340] Advances in CBCT imaging have improved the detection of early healing differences, increasing confidence in observed benefits.[45] GRADE assessment indicates moderate certainty for radiographic success, low-to-moderate certainty for postoperative pain outcomes, and low-to-moderate certainty for early healing advantage. Practical implications APCs may be beneficial in large or through-and-through lesions, where they accelerate healing and improve early recovery (P < 0.05).[19] PRF-based approaches may enable less invasive surgical strategies with high success rates.[42] Combination therapies (e.g., PRF with hydroxyapatite) may further enhance outcomes in complex defects,[46] whereas standalone use offers limited advantage over conventional materials such as MTA in simpler cases.[44] Integration of APCs into clinical protocols may improve tooth retention and reduce surgical morbidity, particularly in high-risk cases. Strengths, limitations, and future research This review has several methodological strengths, including a comprehensive search strategy, inclusion of a large number of clinical studies, and adherence to established methodological standards such as PRISMA guidelines, risk-of-bias assessment, and GRADE evaluation. The inclusion of both REPs and periapical surgery provides a broad clinical perspective. However, limitations must be acknowledged. Meta-analysis was constrained by limited comparable data and ceiling effects in outcomes such as periapical healing, reducing sensitivity to detect differences. Substantial heterogeneity existed in APC preparation protocols, outcome measures, and imaging modalities. In addition, inclusion of nonrandomized studies may introduce bias and reduce the certainty of evidence. Formal assessment of publication bias was not feasible due to the limited number of studies per outcome, and sensitivity analyses were similarly constrained by the small number of studies, potentially affecting the robustness of the findings. Future research should prioritize well-designed RCTs with standardized APC preparation protocols and outcome assessment. The use of CBCT imaging should be encouraged to improve accuracy, and studies incorporating histological evaluation are needed to confirm true pulp–dentin regeneration and underlying biological mechanisms. Overall interpretation In conclusion, APCs represent a promising adjunct in regenerative endodontics and periapical surgery, offering biological and patient-centered advantages without consistently improving hard tissue outcomes. While current evidence supports their use in selected clinical scenarios, particularly where regenerative potential is prioritized, routine adoption cannot yet be recommended due to variability in protocols and limited high-quality evidence. Further well-designed trials are required to establish definitive clinical guidelines. CONCLUSIONS APCs show clinical effectiveness comparable to conventional scaffolds in REPs, particularly in immature teeth, where no consistent superiority was observed across radiographic and clinical outcomes. In mature teeth, APCs showed no statistically significant advantage in restoring pulp sensibility, suggesting a potential role in promoting functional regeneration. In periapical surgery, APCs were associated with enhanced early healing and a nonsignificant reduction in postoperative discomfort, although long-term outcomes are generally similar to conventional approaches. Overall, the current evidence indicates that APCs may be considered a potential adjunct in regenerative endodontics and surgical management; however, their superiority over conventional treatments remains uncertain and requires further high-quality evidence. The interpretation of the findings is limited by heterogeneity in study design, variability in outcome reporting, and ceiling effects in several analyses. Future research should focus on well-designed RCTs with standardized protocols and outcome measures, including histological validation, to establish the true regenerative potential and clinical value of APCs. Conflicts of interest There are no conflicts of interest. Summary plots of Risk-of-bias ROB 2 summary plots for randomised studies. A. Immature teeth, B. Mature teeth, C. Periapical surgery; ROBINS 1 summary plots for non-randomised studies A. Immature teeth and B. Periapical surgery. Traffic-light plots indicate low (green), some concerns/moderate (yellow), and high/serious (red) risk of bias